Literature DB >> 17547993

Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma.

Yoke-Yeow Yap1, Shahid Hassan, Melissa Chan, Pua Kin Choo, Manickam Ravichandran.   

Abstract

OBJECTIVES: This study examines the presence of Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC) by using polymerase chain reaction (PCR). STUDY
DESIGN: Eighty-six postnasal biopsy samples and 71 fine-needle aspirate samples of neck masses were obtained from patients who were clinically suspect for NPC. Genomic DNA was extracted from the samples, and EBNA1, EBNA2, and LMP genes of EBV were detected by PCR. PCR results were compared with NPC histopathology findings.
RESULTS: The sensitivity of PCR to detect EBNA1 (97.14%), EBNA2 (88.57%), and LMP (91.43%) genes of EBV in nasopharyngeal biopsy samples were higher than those in fine-needle aspirate samples.
CONCLUSION: Detection of EBV by PCR in tissue obtained from nasopharyngeal biopsy and fine-needle aspirate samples of neck masses is a relatively inexpensive, reliable, and accurate method of diagnosing NPC. Detection of EBV genes is on par with histopathological examination (HPE) and superior to fine-needle aspirate cytology. SIGNIFICANCE: PCR is an ideal tool for suggesting NPC and guiding the diagnostic workup in occult primary tumors, facilitating earlier diagnosis and reducing morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17547993     DOI: 10.1016/j.otohns.2006.11.027

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

Review 1.  Laboratory assays for Epstein-Barr virus-related disease.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

2.  Dimorphism in the TCRγ-chain repertoire defines 2 types of human immunity to Epstein-Barr virus.

Authors:  Zakia Djaoud; Peter Parham
Journal:  Blood Adv       Date:  2020-04-14

Review 3.  Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.

Authors:  Laurissa Ouaguia; Dhafer Mrizak; Sarah Renaud; Olivier Moralès; Nadira Delhem
Journal:  Mediators Inflamm       Date:  2014-11-30       Impact factor: 4.711

Review 4.  Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.

Authors:  Jens Müller von der Grün; Aykut Tahtali; Shahram Ghanaati; Claus Rödel; Panagiotis Balermpas
Journal:  Radiat Oncol       Date:  2017-05-10       Impact factor: 3.481

5.  Frequency of Epstein Barr Virus Type 1 Among Nasopharyngeal Carcinomas in Iranian Patients

Authors:  Toran Shahani; Manoochehr Makvandi; Alireza Samarbafzadeh; Ali Teimoori; Nastran Ranjbar; Nader saki; Soheila Nikakhlagh; Niloofar Neisi; Zeinab Hosseini; Samira Pourrezaei; Abdolnabi Shabani; Hashem Radmehr; Hamide Mehravaran; Hadis Kiani; Azadeh Haghi
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

6.  Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.

Authors:  Zakia Djaoud; Lisbeth A Guethlein; Amir Horowitz; Tarik Azzi; Neda Nemat-Gorgani; Daniel Olive; David Nadal; Paul J Norman; Christian Münz; Peter Parham
Journal:  J Exp Med       Date:  2017-05-03       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.